nodes	percent_of_prediction	percent_of_DWPC	metapath
Phenobarbital—CYP4B1—urinary bladder cancer	0.484	1	CbGaD
Phenobarbital—CYP4A11—Cisplatin—urinary bladder cancer	0.0428	0.119	CbGbCtD
Phenobarbital—ABCC3—Fluorouracil—urinary bladder cancer	0.0242	0.0671	CbGbCtD
Phenobarbital—CYP2B6—Thiotepa—urinary bladder cancer	0.0215	0.0597	CbGbCtD
Phenobarbital—ABCC3—Cisplatin—urinary bladder cancer	0.0206	0.057	CbGbCtD
Phenobarbital—ABCC3—Etoposide—urinary bladder cancer	0.0202	0.056	CbGbCtD
Phenobarbital—ABCC1—Epirubicin—urinary bladder cancer	0.0159	0.0441	CbGbCtD
Phenobarbital—ABCB1—Mitomycin—urinary bladder cancer	0.0146	0.0404	CbGbCtD
Phenobarbital—ABCC3—Doxorubicin—urinary bladder cancer	0.0138	0.0382	CbGbCtD
Phenobarbital—ABCC3—Methotrexate—urinary bladder cancer	0.0133	0.037	CbGbCtD
Phenobarbital—ABCC1—Etoposide—urinary bladder cancer	0.0124	0.0344	CbGbCtD
Phenobarbital—ABCB11—Doxorubicin—urinary bladder cancer	0.0119	0.033	CbGbCtD
Phenobarbital—CYP1B1—Doxorubicin—urinary bladder cancer	0.0119	0.033	CbGbCtD
Phenobarbital—ABCC2—Carboplatin—urinary bladder cancer	0.0109	0.0303	CbGbCtD
Phenobarbital—CYP2A6—Fluorouracil—urinary bladder cancer	0.0107	0.0298	CbGbCtD
Phenobarbital—ABCC2—Cisplatin—urinary bladder cancer	0.00934	0.0259	CbGbCtD
Phenobarbital—ABCC2—Etoposide—urinary bladder cancer	0.00918	0.0254	CbGbCtD
Phenobarbital—ABCC1—Doxorubicin—urinary bladder cancer	0.00846	0.0234	CbGbCtD
Phenobarbital—ABCC1—Methotrexate—urinary bladder cancer	0.00819	0.0227	CbGbCtD
Phenobarbital—CYP3A4—Thiotepa—urinary bladder cancer	0.00661	0.0183	CbGbCtD
Phenobarbital—ABCC2—Doxorubicin—urinary bladder cancer	0.00626	0.0174	CbGbCtD
Phenobarbital—ABCC2—Methotrexate—urinary bladder cancer	0.00607	0.0168	CbGbCtD
Phenobarbital—CYP2B6—Cisplatin—urinary bladder cancer	0.00594	0.0165	CbGbCtD
Phenobarbital—CYP2E1—Etoposide—urinary bladder cancer	0.00592	0.0164	CbGbCtD
Phenobarbital—CYP2C8—Fluorouracil—urinary bladder cancer	0.0053	0.0147	CbGbCtD
Phenobarbital—CYP3A5—Etoposide—urinary bladder cancer	0.0046	0.0127	CbGbCtD
Phenobarbital—CYP2C8—Etoposide—urinary bladder cancer	0.00442	0.0123	CbGbCtD
Phenobarbital—ABCB1—Gemcitabine—urinary bladder cancer	0.00419	0.0116	CbGbCtD
Phenobarbital—CYP1A2—Fluorouracil—urinary bladder cancer	0.0041	0.0114	CbGbCtD
Phenobarbital—CYP2B6—Doxorubicin—urinary bladder cancer	0.00398	0.011	CbGbCtD
Phenobarbital—CYP2C9—Fluorouracil—urinary bladder cancer	0.00369	0.0102	CbGbCtD
Phenobarbital—CYP1A2—Etoposide—urinary bladder cancer	0.00342	0.00949	CbGbCtD
Phenobarbital—CYP2C9—Cisplatin—urinary bladder cancer	0.00314	0.0087	CbGbCtD
Phenobarbital—ABCB1—Cisplatin—urinary bladder cancer	0.00305	0.00844	CbGbCtD
Phenobarbital—ABCB1—Etoposide—urinary bladder cancer	0.00299	0.00829	CbGbCtD
Phenobarbital—ABCB1—Doxorubicin—urinary bladder cancer	0.00204	0.00566	CbGbCtD
Phenobarbital—ABCB1—Methotrexate—urinary bladder cancer	0.00198	0.00548	CbGbCtD
Phenobarbital—CYP3A4—Etoposide—urinary bladder cancer	0.00179	0.00497	CbGbCtD
Phenobarbital—CYP4B1—prostate gland—urinary bladder cancer	0.00145	0.0448	CbGeAlD
Phenobarbital—CYP2C19—urine—urinary bladder cancer	0.00128	0.0394	CbGeAlD
Phenobarbital—CYP3A4—Doxorubicin—urinary bladder cancer	0.00122	0.00339	CbGbCtD
Phenobarbital—CYP4A11—renal system—urinary bladder cancer	0.00111	0.0342	CbGeAlD
Phenobarbital—CYP1A2—urine—urinary bladder cancer	0.00104	0.0321	CbGeAlD
Phenobarbital—CYP2C9—urine—urinary bladder cancer	0.000991	0.0305	CbGeAlD
Phenobarbital—CYP4B1—urethra—urinary bladder cancer	0.000973	0.03	CbGeAlD
Phenobarbital—CYP2E1—urine—urinary bladder cancer	0.000939	0.0289	CbGeAlD
Phenobarbital—SLCO2A1—prostate gland—urinary bladder cancer	0.00087	0.0268	CbGeAlD
Phenobarbital—CYP4A11—vagina—urinary bladder cancer	0.000804	0.0248	CbGeAlD
Phenobarbital—CYP4B1—female reproductive system—urinary bladder cancer	0.000794	0.0244	CbGeAlD
Phenobarbital—CYP3A4—urine—urinary bladder cancer	0.000755	0.0233	CbGeAlD
Phenobarbital—SLCO2A1—seminal vesicle—urinary bladder cancer	0.000736	0.0227	CbGeAlD
Phenobarbital—CYP4B1—vagina—urinary bladder cancer	0.000718	0.0221	CbGeAlD
Phenobarbital—CYP2A6—prostate gland—urinary bladder cancer	0.000713	0.022	CbGeAlD
Phenobarbital—ABCC3—prostate gland—urinary bladder cancer	0.000668	0.0206	CbGeAlD
Phenobarbital—SLCO2A1—epithelium—urinary bladder cancer	0.000639	0.0197	CbGeAlD
Phenobarbital—CYP2A6—seminal vesicle—urinary bladder cancer	0.000603	0.0186	CbGeAlD
Phenobarbital—SLCO2A1—renal system—urinary bladder cancer	0.000593	0.0183	CbGeAlD
Phenobarbital—SLCO2A1—urethra—urinary bladder cancer	0.000582	0.0179	CbGeAlD
Phenobarbital—ABCC2—prostate gland—urinary bladder cancer	0.000534	0.0164	CbGeAlD
Phenobarbital—CYP2C18—vagina—urinary bladder cancer	0.000533	0.0164	CbGeAlD
Phenobarbital—CYP1B1—prostate gland—urinary bladder cancer	0.000523	0.0161	CbGeAlD
Phenobarbital—CHRNA7—renal system—urinary bladder cancer	0.000486	0.015	CbGeAlD
Phenobarbital—CHRFAM7A—female reproductive system—urinary bladder cancer	0.000482	0.0149	CbGeAlD
Phenobarbital—SLCO2A1—female reproductive system—urinary bladder cancer	0.000475	0.0146	CbGeAlD
Phenobarbital—ABCC1—prostate gland—urinary bladder cancer	0.00047	0.0145	CbGeAlD
Phenobarbital—CYP4B1—lymph node—urinary bladder cancer	0.000464	0.0143	CbGeAlD
Phenobarbital—ABCC3—renal system—urinary bladder cancer	0.000455	0.014	CbGeAlD
Phenobarbital—SLCO2A1—vagina—urinary bladder cancer	0.000429	0.0132	CbGeAlD
Phenobarbital—ABCC1—seminal vesicle—urinary bladder cancer	0.000398	0.0122	CbGeAlD
Phenobarbital—CHRNA7—female reproductive system—urinary bladder cancer	0.00039	0.012	CbGeAlD
Phenobarbital—CYP1B1—smooth muscle tissue—urinary bladder cancer	0.00037	0.0114	CbGeAlD
Phenobarbital—ABCC3—female reproductive system—urinary bladder cancer	0.000365	0.0112	CbGeAlD
Phenobarbital—ABCC2—renal system—urinary bladder cancer	0.000364	0.0112	CbGeAlD
Phenobarbital—CYP3A5—prostate gland—urinary bladder cancer	0.000361	0.0111	CbGeAlD
Phenobarbital—CYP1B1—renal system—urinary bladder cancer	0.000356	0.011	CbGeAlD
Phenobarbital—CYP2A6—vagina—urinary bladder cancer	0.000352	0.0108	CbGeAlD
Phenobarbital—CYP2E1—prostate gland—urinary bladder cancer	0.000337	0.0104	CbGeAlD
Phenobarbital—ABCC1—urethra—urinary bladder cancer	0.000315	0.0097	CbGeAlD
Phenobarbital—ABCC2—female reproductive system—urinary bladder cancer	0.000291	0.00897	CbGeAlD
Phenobarbital—CYP1B1—female reproductive system—urinary bladder cancer	0.000285	0.00879	CbGeAlD
Phenobarbital—CYP2E1—seminal vesicle—urinary bladder cancer	0.000285	0.00878	CbGeAlD
Phenobarbital—SLCO2A1—lymph node—urinary bladder cancer	0.000278	0.00856	CbGeAlD
Phenobarbital—CYP2C8—renal system—urinary bladder cancer	0.000273	0.0084	CbGeAlD
Phenobarbital—CYP1A1—epithelium—urinary bladder cancer	0.000272	0.00836	CbGeAlD
Phenobarbital—CYP1A2—renal system—urinary bladder cancer	0.000255	0.00787	CbGeAlD
Phenobarbital—CYP1A1—renal system—urinary bladder cancer	0.000252	0.00776	CbGeAlD
Phenobarbital—Feeling abnormal—Mitomycin—urinary bladder cancer	0.000248	0.00464	CcSEcCtD
Phenobarbital—CYP1A1—urethra—urinary bladder cancer	0.000247	0.00762	CbGeAlD
Phenobarbital—CYP3A5—renal system—urinary bladder cancer	0.000246	0.00759	CbGeAlD
Phenobarbital—CYP2B6—renal system—urinary bladder cancer	0.000245	0.00754	CbGeAlD
Phenobarbital—Irritability—Fluorouracil—urinary bladder cancer	0.000243	0.00454	CcSEcCtD
Phenobarbital—Ataxia—Fluorouracil—urinary bladder cancer	0.000239	0.00448	CcSEcCtD
Phenobarbital—Nystagmus—Epirubicin—urinary bladder cancer	0.000239	0.00447	CcSEcCtD
Phenobarbital—Body temperature increased—Mitomycin—urinary bladder cancer	0.000237	0.00445	CcSEcCtD
Phenobarbital—Blister—Epirubicin—urinary bladder cancer	0.000237	0.00443	CcSEcCtD
Phenobarbital—Renal failure—Thiotepa—urinary bladder cancer	0.000233	0.00436	CcSEcCtD
Phenobarbital—Toxic epidermal necrolysis—Gemcitabine—urinary bladder cancer	0.000233	0.00436	CcSEcCtD
Phenobarbital—Necrosis—Methotrexate—urinary bladder cancer	0.000232	0.00435	CcSEcCtD
Phenobarbital—ABCC1—vagina—urinary bladder cancer	0.000232	0.00715	CbGeAlD
Phenobarbital—Irritability—Cisplatin—urinary bladder cancer	0.00023	0.00431	CcSEcCtD
Phenobarbital—CYP2E1—renal system—urinary bladder cancer	0.00023	0.00708	CbGeAlD
Phenobarbital—CYP2C19—vagina—urinary bladder cancer	0.000226	0.00697	CbGeAlD
Phenobarbital—CYP2E1—urethra—urinary bladder cancer	0.000226	0.00695	CbGeAlD
Phenobarbital—Nystagmus—Doxorubicin—urinary bladder cancer	0.000221	0.00414	CcSEcCtD
Phenobarbital—Blister—Doxorubicin—urinary bladder cancer	0.000219	0.0041	CcSEcCtD
Phenobarbital—CYP2C8—female reproductive system—urinary bladder cancer	0.000219	0.00673	CbGeAlD
Phenobarbital—Necrosis—Epirubicin—urinary bladder cancer	0.000217	0.00407	CcSEcCtD
Phenobarbital—Apnoea—Methotrexate—urinary bladder cancer	0.000215	0.00403	CcSEcCtD
Phenobarbital—ABCC3—lymph node—urinary bladder cancer	0.000213	0.00657	CbGeAlD
Phenobarbital—Hallucination—Thiotepa—urinary bladder cancer	0.000212	0.00396	CcSEcCtD
Phenobarbital—Extravasation—Methotrexate—urinary bladder cancer	0.000209	0.00391	CcSEcCtD
Phenobarbital—Liver injury—Epirubicin—urinary bladder cancer	0.000203	0.0038	CcSEcCtD
Phenobarbital—CYP1A1—female reproductive system—urinary bladder cancer	0.000202	0.00621	CbGeAlD
Phenobarbital—Necrosis—Doxorubicin—urinary bladder cancer	0.000201	0.00376	CcSEcCtD
Phenobarbital—Toxic epidermal necrolysis—Etoposide—urinary bladder cancer	0.000199	0.00372	CcSEcCtD
Phenobarbital—Dizziness—Mitomycin—urinary bladder cancer	0.000199	0.00372	CcSEcCtD
Phenobarbital—Delirium—Epirubicin—urinary bladder cancer	0.000198	0.00371	CcSEcCtD
Phenobarbital—CYP2C8—vagina—urinary bladder cancer	0.000198	0.00609	CbGeAlD
Phenobarbital—Stevens-Johnson syndrome—Gemcitabine—urinary bladder cancer	0.000198	0.0037	CcSEcCtD
Phenobarbital—CYP2B6—female reproductive system—urinary bladder cancer	0.000196	0.00604	CbGeAlD
Phenobarbital—Renal failure—Gemcitabine—urinary bladder cancer	0.000196	0.00367	CcSEcCtD
Phenobarbital—Extravasation—Epirubicin—urinary bladder cancer	0.000195	0.00366	CcSEcCtD
Phenobarbital—CYP2C9—female reproductive system—urinary bladder cancer	0.000194	0.00598	CbGeAlD
Phenobarbital—ABCB1—prostate gland—urinary bladder cancer	0.000192	0.00591	CbGeAlD
Phenobarbital—Vomiting—Mitomycin—urinary bladder cancer	0.000191	0.00358	CcSEcCtD
Phenobarbital—Rash—Mitomycin—urinary bladder cancer	0.000189	0.00355	CcSEcCtD
Phenobarbital—Dermatitis—Mitomycin—urinary bladder cancer	0.000189	0.00354	CcSEcCtD
Phenobarbital—Headache—Mitomycin—urinary bladder cancer	0.000188	0.00352	CcSEcCtD
Phenobarbital—Liver injury—Doxorubicin—urinary bladder cancer	0.000187	0.00351	CcSEcCtD
Phenobarbital—Thinking abnormal—Epirubicin—urinary bladder cancer	0.000186	0.00349	CcSEcCtD
Phenobarbital—Hypocalcaemia—Epirubicin—urinary bladder cancer	0.000186	0.00349	CcSEcCtD
Phenobarbital—Respiratory failure—Methotrexate—urinary bladder cancer	0.000186	0.00347	CcSEcCtD
Phenobarbital—Erythema—Thiotepa—urinary bladder cancer	0.000185	0.00347	CcSEcCtD
Phenobarbital—CYP3A4—renal system—urinary bladder cancer	0.000185	0.00569	CbGeAlD
Phenobarbital—CYP2E1—female reproductive system—urinary bladder cancer	0.000184	0.00567	CbGeAlD
Phenobarbital—Delirium—Doxorubicin—urinary bladder cancer	0.000183	0.00344	CcSEcCtD
Phenobarbital—Renal failure—Cisplatin—urinary bladder cancer	0.000183	0.00342	CcSEcCtD
Phenobarbital—CYP1A1—vagina—urinary bladder cancer	0.000182	0.00562	CbGeAlD
Phenobarbital—Tension—Thiotepa—urinary bladder cancer	0.000182	0.0034	CcSEcCtD
Phenobarbital—Extravasation—Doxorubicin—urinary bladder cancer	0.000181	0.00339	CcSEcCtD
Phenobarbital—Nervousness—Thiotepa—urinary bladder cancer	0.00018	0.00337	CcSEcCtD
Phenobarbital—Nausea—Mitomycin—urinary bladder cancer	0.000178	0.00334	CcSEcCtD
Phenobarbital—CYP3A5—vagina—urinary bladder cancer	0.000178	0.00549	CbGeAlD
Phenobarbital—CYP2B6—vagina—urinary bladder cancer	0.000177	0.00546	CbGeAlD
Phenobarbital—Depressed level of consciousness—Methotrexate—urinary bladder cancer	0.000176	0.0033	CcSEcCtD
Phenobarbital—Hypocalcaemia—Doxorubicin—urinary bladder cancer	0.000172	0.00323	CcSEcCtD
Phenobarbital—Thinking abnormal—Doxorubicin—urinary bladder cancer	0.000172	0.00323	CcSEcCtD
Phenobarbital—Hepatocellular injury—Epirubicin—urinary bladder cancer	0.000171	0.00319	CcSEcCtD
Phenobarbital—ABCC2—lymph node—urinary bladder cancer	0.00017	0.00525	CbGeAlD
Phenobarbital—Agitation—Thiotepa—urinary bladder cancer	0.00017	0.00319	CcSEcCtD
Phenobarbital—Bradycardia—Cisplatin—urinary bladder cancer	0.00017	0.00318	CcSEcCtD
Phenobarbital—Injection site reaction—Epirubicin—urinary bladder cancer	0.00017	0.00317	CcSEcCtD
Phenobarbital—Erythema multiforme—Gemcitabine—urinary bladder cancer	0.000169	0.00317	CcSEcCtD
Phenobarbital—Stevens-Johnson syndrome—Etoposide—urinary bladder cancer	0.000169	0.00316	CcSEcCtD
Phenobarbital—Renal failure—Etoposide—urinary bladder cancer	0.000167	0.00313	CcSEcCtD
Phenobarbital—CYP1B1—lymph node—urinary bladder cancer	0.000167	0.00514	CbGeAlD
Phenobarbital—Coma—Methotrexate—urinary bladder cancer	0.000166	0.00312	CcSEcCtD
Phenobarbital—ABCB1—seminal vesicle—urinary bladder cancer	0.000162	0.005	CbGeAlD
Phenobarbital—Hepatocellular injury—Doxorubicin—urinary bladder cancer	0.000158	0.00295	CcSEcCtD
Phenobarbital—Arthralgia—Thiotepa—urinary bladder cancer	0.000158	0.00295	CcSEcCtD
Phenobarbital—Myalgia—Thiotepa—urinary bladder cancer	0.000158	0.00295	CcSEcCtD
Phenobarbital—Anxiety—Thiotepa—urinary bladder cancer	0.000157	0.00294	CcSEcCtD
Phenobarbital—Injection site reaction—Doxorubicin—urinary bladder cancer	0.000157	0.00294	CcSEcCtD
Phenobarbital—Coma—Epirubicin—urinary bladder cancer	0.000156	0.00292	CcSEcCtD
Phenobarbital—Erythema—Gemcitabine—urinary bladder cancer	0.000156	0.00292	CcSEcCtD
Phenobarbital—Erythema—Fluorouracil—urinary bladder cancer	0.000153	0.00287	CcSEcCtD
Phenobarbital—Confusional state—Thiotepa—urinary bladder cancer	0.000152	0.00285	CcSEcCtD
Phenobarbital—ABCC1—lymph node—urinary bladder cancer	0.00015	0.00462	CbGeAlD
Phenobarbital—CYP3A4—female reproductive system—urinary bladder cancer	0.000148	0.00456	CbGeAlD
Phenobarbital—Mental disability—Epirubicin—urinary bladder cancer	0.000148	0.00277	CcSEcCtD
Phenobarbital—Erythema—Cisplatin—urinary bladder cancer	0.000145	0.00272	CcSEcCtD
Phenobarbital—Erythema multiforme—Etoposide—urinary bladder cancer	0.000144	0.0027	CcSEcCtD
Phenobarbital—Coma—Doxorubicin—urinary bladder cancer	0.000144	0.0027	CcSEcCtD
Phenobarbital—ABCB1—epithelium—urinary bladder cancer	0.000141	0.00434	CbGeAlD
Phenobarbital—Dermatitis exfoliative—Methotrexate—urinary bladder cancer	0.00014	0.00263	CcSEcCtD
Phenobarbital—Musculoskeletal discomfort—Thiotepa—urinary bladder cancer	0.000138	0.00258	CcSEcCtD
Phenobarbital—Mental disability—Doxorubicin—urinary bladder cancer	0.000137	0.00256	CcSEcCtD
Phenobarbital—Lethargy—Methotrexate—urinary bladder cancer	0.000135	0.00253	CcSEcCtD
Phenobarbital—Somnolence—Thiotepa—urinary bladder cancer	0.000134	0.00252	CcSEcCtD
Phenobarbital—Arthralgia—Gemcitabine—urinary bladder cancer	0.000133	0.00248	CcSEcCtD
Phenobarbital—Myalgia—Gemcitabine—urinary bladder cancer	0.000133	0.00248	CcSEcCtD
Phenobarbital—Dermatitis exfoliative—Epirubicin—urinary bladder cancer	0.000131	0.00246	CcSEcCtD
Phenobarbital—ABCB1—renal system—urinary bladder cancer	0.000131	0.00403	CbGeAlD
Phenobarbital—Myalgia—Fluorouracil—urinary bladder cancer	0.00013	0.00244	CcSEcCtD
Phenobarbital—Dermatitis bullous—Epirubicin—urinary bladder cancer	0.00013	0.00243	CcSEcCtD
Phenobarbital—Constipation—Thiotepa—urinary bladder cancer	0.000129	0.00242	CcSEcCtD
Phenobarbital—Pain—Thiotepa—urinary bladder cancer	0.000129	0.00242	CcSEcCtD
Phenobarbital—ABCB1—urethra—urinary bladder cancer	0.000129	0.00396	CbGeAlD
Phenobarbital—Lethargy—Epirubicin—urinary bladder cancer	0.000126	0.00237	CcSEcCtD
Phenobarbital—Irritability—Methotrexate—urinary bladder cancer	0.000126	0.00236	CcSEcCtD
Phenobarbital—Confusional state—Fluorouracil—urinary bladder cancer	0.000126	0.00236	CcSEcCtD
Phenobarbital—Mood swings—Methotrexate—urinary bladder cancer	0.000125	0.00235	CcSEcCtD
Phenobarbital—Feeling abnormal—Thiotepa—urinary bladder cancer	0.000125	0.00233	CcSEcCtD
Phenobarbital—Ataxia—Methotrexate—urinary bladder cancer	0.000124	0.00233	CcSEcCtD
Phenobarbital—Myalgia—Cisplatin—urinary bladder cancer	0.000124	0.00231	CcSEcCtD
Phenobarbital—Anxiety—Cisplatin—urinary bladder cancer	0.000123	0.00231	CcSEcCtD
Phenobarbital—Affect lability—Epirubicin—urinary bladder cancer	0.000122	0.00228	CcSEcCtD
Phenobarbital—Dermatitis exfoliative—Doxorubicin—urinary bladder cancer	0.000121	0.00227	CcSEcCtD
Phenobarbital—Urticaria—Thiotepa—urinary bladder cancer	0.00012	0.00225	CcSEcCtD
Phenobarbital—Dermatitis bullous—Doxorubicin—urinary bladder cancer	0.00012	0.00224	CcSEcCtD
Phenobarbital—Vertigo—Etoposide—urinary bladder cancer	0.000119	0.00224	CcSEcCtD
Phenobarbital—Body temperature increased—Thiotepa—urinary bladder cancer	0.000119	0.00224	CcSEcCtD
Phenobarbital—Toxic epidermal necrolysis—Methotrexate—urinary bladder cancer	0.000119	0.00223	CcSEcCtD
Phenobarbital—Hypotension—Gemcitabine—urinary bladder cancer	0.000119	0.00222	CcSEcCtD
Phenobarbital—CYP1A1—lymph node—urinary bladder cancer	0.000118	0.00363	CbGeAlD
Phenobarbital—Mood swings—Epirubicin—urinary bladder cancer	0.000117	0.0022	CcSEcCtD
Phenobarbital—Loss of consciousness—Etoposide—urinary bladder cancer	0.000117	0.00219	CcSEcCtD
Phenobarbital—Lethargy—Doxorubicin—urinary bladder cancer	0.000117	0.00219	CcSEcCtD
Phenobarbital—Hypotension—Fluorouracil—urinary bladder cancer	0.000117	0.00219	CcSEcCtD
Phenobarbital—Ataxia—Epirubicin—urinary bladder cancer	0.000116	0.00218	CcSEcCtD
Phenobarbital—Musculoskeletal discomfort—Gemcitabine—urinary bladder cancer	0.000116	0.00217	CcSEcCtD
Phenobarbital—Asthma—Methotrexate—urinary bladder cancer	0.000114	0.00214	CcSEcCtD
Phenobarbital—Musculoskeletal discomfort—Fluorouracil—urinary bladder cancer	0.000114	0.00213	CcSEcCtD
Phenobarbital—Somnolence—Gemcitabine—urinary bladder cancer	0.000113	0.00212	CcSEcCtD
Phenobarbital—Affect lability—Doxorubicin—urinary bladder cancer	0.000113	0.00211	CcSEcCtD
Phenobarbital—Toxic epidermal necrolysis—Epirubicin—urinary bladder cancer	0.000111	0.00209	CcSEcCtD
Phenobarbital—Hypersensitivity—Thiotepa—urinary bladder cancer	0.000111	0.00208	CcSEcCtD
Phenobarbital—Somnolence—Fluorouracil—urinary bladder cancer	0.000111	0.00208	CcSEcCtD
Phenobarbital—Hypotension—Cisplatin—urinary bladder cancer	0.000111	0.00207	CcSEcCtD
Phenobarbital—Confusional state—Etoposide—urinary bladder cancer	0.000109	0.00205	CcSEcCtD
Phenobarbital—Pain—Gemcitabine—urinary bladder cancer	0.000109	0.00204	CcSEcCtD
Phenobarbital—Constipation—Gemcitabine—urinary bladder cancer	0.000109	0.00204	CcSEcCtD
Phenobarbital—Mood swings—Doxorubicin—urinary bladder cancer	0.000108	0.00203	CcSEcCtD
Phenobarbital—Musculoskeletal discomfort—Cisplatin—urinary bladder cancer	0.000108	0.00202	CcSEcCtD
Phenobarbital—Ataxia—Doxorubicin—urinary bladder cancer	0.000108	0.00202	CcSEcCtD
Phenobarbital—Asthma—Epirubicin—urinary bladder cancer	0.000107	0.002	CcSEcCtD
Phenobarbital—Pain—Fluorouracil—urinary bladder cancer	0.000107	0.002	CcSEcCtD
Phenobarbital—ABCB1—female reproductive system—urinary bladder cancer	0.000105	0.00323	CbGeAlD
Phenobarbital—Feeling abnormal—Gemcitabine—urinary bladder cancer	0.000105	0.00196	CcSEcCtD
Phenobarbital—Toxic epidermal necrolysis—Doxorubicin—urinary bladder cancer	0.000103	0.00193	CcSEcCtD
Phenobarbital—Feeling abnormal—Fluorouracil—urinary bladder cancer	0.000103	0.00193	CcSEcCtD
Phenobarbital—Drowsiness—Methotrexate—urinary bladder cancer	0.000102	0.00191	CcSEcCtD
Phenobarbital—Hypotension—Etoposide—urinary bladder cancer	0.000101	0.0019	CcSEcCtD
Phenobarbital—Pain—Cisplatin—urinary bladder cancer	0.000101	0.0019	CcSEcCtD
Phenobarbital—Stevens-Johnson syndrome—Methotrexate—urinary bladder cancer	0.000101	0.00189	CcSEcCtD
Phenobarbital—Body temperature increased—Gemcitabine—urinary bladder cancer	0.0001	0.00188	CcSEcCtD
Phenobarbital—Renal failure—Methotrexate—urinary bladder cancer	0.0001	0.00188	CcSEcCtD
Phenobarbital—Dizziness—Thiotepa—urinary bladder cancer	9.99e-05	0.00187	CcSEcCtD
Phenobarbital—Urticaria—Fluorouracil—urinary bladder cancer	9.93e-05	0.00186	CcSEcCtD
Phenobarbital—Asthma—Doxorubicin—urinary bladder cancer	9.9e-05	0.00185	CcSEcCtD
Phenobarbital—Body temperature increased—Fluorouracil—urinary bladder cancer	9.88e-05	0.00185	CcSEcCtD
Phenobarbital—Feeling abnormal—Cisplatin—urinary bladder cancer	9.76e-05	0.00183	CcSEcCtD
Phenobarbital—Somnolence—Etoposide—urinary bladder cancer	9.65e-05	0.00181	CcSEcCtD
Phenobarbital—Vomiting—Thiotepa—urinary bladder cancer	9.61e-05	0.0018	CcSEcCtD
Phenobarbital—Drowsiness—Epirubicin—urinary bladder cancer	9.54e-05	0.00179	CcSEcCtD
Phenobarbital—Rash—Thiotepa—urinary bladder cancer	9.53e-05	0.00178	CcSEcCtD
Phenobarbital—Dermatitis—Thiotepa—urinary bladder cancer	9.52e-05	0.00178	CcSEcCtD
Phenobarbital—ABCB1—vagina—urinary bladder cancer	9.48e-05	0.00292	CbGeAlD
Phenobarbital—Headache—Thiotepa—urinary bladder cancer	9.47e-05	0.00177	CcSEcCtD
Phenobarbital—Stevens-Johnson syndrome—Epirubicin—urinary bladder cancer	9.46e-05	0.00177	CcSEcCtD
Phenobarbital—Renal failure—Epirubicin—urinary bladder cancer	9.38e-05	0.00176	CcSEcCtD
Phenobarbital—Body temperature increased—Cisplatin—urinary bladder cancer	9.36e-05	0.00175	CcSEcCtD
Phenobarbital—Constipation—Etoposide—urinary bladder cancer	9.28e-05	0.00174	CcSEcCtD
Phenobarbital—Pain—Etoposide—urinary bladder cancer	9.28e-05	0.00174	CcSEcCtD
Phenobarbital—Hypersensitivity—Fluorouracil—urinary bladder cancer	9.21e-05	0.00172	CcSEcCtD
Phenobarbital—Hepatitis—Methotrexate—urinary bladder cancer	9.15e-05	0.00171	CcSEcCtD
Phenobarbital—Nausea—Thiotepa—urinary bladder cancer	8.97e-05	0.00168	CcSEcCtD
Phenobarbital—Feeling abnormal—Etoposide—urinary bladder cancer	8.94e-05	0.00167	CcSEcCtD
Phenobarbital—Drowsiness—Doxorubicin—urinary bladder cancer	8.83e-05	0.00165	CcSEcCtD
Phenobarbital—Stevens-Johnson syndrome—Doxorubicin—urinary bladder cancer	8.75e-05	0.00164	CcSEcCtD
Phenobarbital—Hypersensitivity—Cisplatin—urinary bladder cancer	8.73e-05	0.00163	CcSEcCtD
Phenobarbital—Bradycardia—Epirubicin—urinary bladder cancer	8.72e-05	0.00163	CcSEcCtD
Phenobarbital—Renal failure—Doxorubicin—urinary bladder cancer	8.68e-05	0.00162	CcSEcCtD
Phenobarbital—Erythema multiforme—Methotrexate—urinary bladder cancer	8.65e-05	0.00162	CcSEcCtD
Phenobarbital—Urticaria—Etoposide—urinary bladder cancer	8.62e-05	0.00161	CcSEcCtD
Phenobarbital—Body temperature increased—Etoposide—urinary bladder cancer	8.58e-05	0.00161	CcSEcCtD
Phenobarbital—Hepatitis—Epirubicin—urinary bladder cancer	8.56e-05	0.0016	CcSEcCtD
Phenobarbital—Dizziness—Fluorouracil—urinary bladder cancer	8.26e-05	0.00155	CcSEcCtD
Phenobarbital—Erythema multiforme—Epirubicin—urinary bladder cancer	8.1e-05	0.00152	CcSEcCtD
Phenobarbital—Vomiting—Gemcitabine—urinary bladder cancer	8.08e-05	0.00151	CcSEcCtD
Phenobarbital—Bradycardia—Doxorubicin—urinary bladder cancer	8.07e-05	0.00151	CcSEcCtD
Phenobarbital—Rash—Gemcitabine—urinary bladder cancer	8.01e-05	0.0015	CcSEcCtD
Phenobarbital—Dermatitis—Gemcitabine—urinary bladder cancer	8.01e-05	0.0015	CcSEcCtD
Phenobarbital—Hypersensitivity—Etoposide—urinary bladder cancer	8e-05	0.0015	CcSEcCtD
Phenobarbital—Erythema—Methotrexate—urinary bladder cancer	7.97e-05	0.00149	CcSEcCtD
Phenobarbital—Headache—Gemcitabine—urinary bladder cancer	7.96e-05	0.00149	CcSEcCtD
Phenobarbital—Vomiting—Fluorouracil—urinary bladder cancer	7.95e-05	0.00149	CcSEcCtD
Phenobarbital—Hepatitis—Doxorubicin—urinary bladder cancer	7.92e-05	0.00148	CcSEcCtD
Phenobarbital—Rash—Fluorouracil—urinary bladder cancer	7.88e-05	0.00148	CcSEcCtD
Phenobarbital—Dermatitis—Fluorouracil—urinary bladder cancer	7.87e-05	0.00147	CcSEcCtD
Phenobarbital—Headache—Fluorouracil—urinary bladder cancer	7.83e-05	0.00147	CcSEcCtD
Phenobarbital—Nausea—Gemcitabine—urinary bladder cancer	7.55e-05	0.00141	CcSEcCtD
Phenobarbital—Vomiting—Cisplatin—urinary bladder cancer	7.53e-05	0.00141	CcSEcCtD
Phenobarbital—Erythema multiforme—Doxorubicin—urinary bladder cancer	7.49e-05	0.0014	CcSEcCtD
Phenobarbital—Rash—Cisplatin—urinary bladder cancer	7.47e-05	0.0014	CcSEcCtD
Phenobarbital—Dermatitis—Cisplatin—urinary bladder cancer	7.46e-05	0.0014	CcSEcCtD
Phenobarbital—Erythema—Epirubicin—urinary bladder cancer	7.45e-05	0.0014	CcSEcCtD
Phenobarbital—Nausea—Fluorouracil—urinary bladder cancer	7.42e-05	0.00139	CcSEcCtD
Phenobarbital—Tension—Epirubicin—urinary bladder cancer	7.31e-05	0.00137	CcSEcCtD
Phenobarbital—Nervousness—Epirubicin—urinary bladder cancer	7.24e-05	0.00136	CcSEcCtD
Phenobarbital—Dizziness—Etoposide—urinary bladder cancer	7.18e-05	0.00134	CcSEcCtD
Phenobarbital—Vertigo—Methotrexate—urinary bladder cancer	7.16e-05	0.00134	CcSEcCtD
Phenobarbital—Nausea—Cisplatin—urinary bladder cancer	7.04e-05	0.00132	CcSEcCtD
Phenobarbital—Vomiting—Etoposide—urinary bladder cancer	6.9e-05	0.00129	CcSEcCtD
Phenobarbital—Erythema—Doxorubicin—urinary bladder cancer	6.9e-05	0.00129	CcSEcCtD
Phenobarbital—Agitation—Epirubicin—urinary bladder cancer	6.85e-05	0.00128	CcSEcCtD
Phenobarbital—Rash—Etoposide—urinary bladder cancer	6.84e-05	0.00128	CcSEcCtD
Phenobarbital—Dermatitis—Etoposide—urinary bladder cancer	6.84e-05	0.00128	CcSEcCtD
Phenobarbital—Headache—Etoposide—urinary bladder cancer	6.8e-05	0.00127	CcSEcCtD
Phenobarbital—Myalgia—Methotrexate—urinary bladder cancer	6.78e-05	0.00127	CcSEcCtD
Phenobarbital—Arthralgia—Methotrexate—urinary bladder cancer	6.78e-05	0.00127	CcSEcCtD
Phenobarbital—Tension—Doxorubicin—urinary bladder cancer	6.77e-05	0.00127	CcSEcCtD
Phenobarbital—Nervousness—Doxorubicin—urinary bladder cancer	6.7e-05	0.00125	CcSEcCtD
Phenobarbital—Vertigo—Epirubicin—urinary bladder cancer	6.7e-05	0.00125	CcSEcCtD
Phenobarbital—Syncope—Epirubicin—urinary bladder cancer	6.68e-05	0.00125	CcSEcCtD
Phenobarbital—Confusional state—Methotrexate—urinary bladder cancer	6.55e-05	0.00123	CcSEcCtD
Phenobarbital—Loss of consciousness—Epirubicin—urinary bladder cancer	6.55e-05	0.00123	CcSEcCtD
Phenobarbital—Nausea—Etoposide—urinary bladder cancer	6.45e-05	0.00121	CcSEcCtD
Phenobarbital—Myalgia—Epirubicin—urinary bladder cancer	6.35e-05	0.00119	CcSEcCtD
Phenobarbital—Arthralgia—Epirubicin—urinary bladder cancer	6.35e-05	0.00119	CcSEcCtD
Phenobarbital—Agitation—Doxorubicin—urinary bladder cancer	6.34e-05	0.00119	CcSEcCtD
Phenobarbital—Anxiety—Epirubicin—urinary bladder cancer	6.32e-05	0.00118	CcSEcCtD
Phenobarbital—Vertigo—Doxorubicin—urinary bladder cancer	6.2e-05	0.00116	CcSEcCtD
Phenobarbital—Syncope—Doxorubicin—urinary bladder cancer	6.19e-05	0.00116	CcSEcCtD
Phenobarbital—Confusional state—Epirubicin—urinary bladder cancer	6.13e-05	0.00115	CcSEcCtD
Phenobarbital—ABCB1—lymph node—urinary bladder cancer	6.13e-05	0.00189	CbGeAlD
Phenobarbital—Hypotension—Methotrexate—urinary bladder cancer	6.07e-05	0.00114	CcSEcCtD
Phenobarbital—Loss of consciousness—Doxorubicin—urinary bladder cancer	6.06e-05	0.00114	CcSEcCtD
Phenobarbital—Shock—Epirubicin—urinary bladder cancer	5.99e-05	0.00112	CcSEcCtD
Phenobarbital—Musculoskeletal discomfort—Methotrexate—urinary bladder cancer	5.92e-05	0.00111	CcSEcCtD
Phenobarbital—Myalgia—Doxorubicin—urinary bladder cancer	5.87e-05	0.0011	CcSEcCtD
Phenobarbital—Arthralgia—Doxorubicin—urinary bladder cancer	5.87e-05	0.0011	CcSEcCtD
Phenobarbital—Anxiety—Doxorubicin—urinary bladder cancer	5.85e-05	0.0011	CcSEcCtD
Phenobarbital—Somnolence—Methotrexate—urinary bladder cancer	5.78e-05	0.00108	CcSEcCtD
Phenobarbital—Hypotension—Epirubicin—urinary bladder cancer	5.68e-05	0.00106	CcSEcCtD
Phenobarbital—Confusional state—Doxorubicin—urinary bladder cancer	5.68e-05	0.00106	CcSEcCtD
Phenobarbital—Pain—Methotrexate—urinary bladder cancer	5.56e-05	0.00104	CcSEcCtD
Phenobarbital—Musculoskeletal discomfort—Epirubicin—urinary bladder cancer	5.54e-05	0.00104	CcSEcCtD
Phenobarbital—Shock—Doxorubicin—urinary bladder cancer	5.54e-05	0.00104	CcSEcCtD
Phenobarbital—Somnolence—Epirubicin—urinary bladder cancer	5.41e-05	0.00101	CcSEcCtD
Phenobarbital—Feeling abnormal—Methotrexate—urinary bladder cancer	5.36e-05	0.001	CcSEcCtD
Phenobarbital—Hypotension—Doxorubicin—urinary bladder cancer	5.26e-05	0.000985	CcSEcCtD
Phenobarbital—Constipation—Epirubicin—urinary bladder cancer	5.2e-05	0.000974	CcSEcCtD
Phenobarbital—Pain—Epirubicin—urinary bladder cancer	5.2e-05	0.000974	CcSEcCtD
Phenobarbital—Urticaria—Methotrexate—urinary bladder cancer	5.16e-05	0.000967	CcSEcCtD
Phenobarbital—Body temperature increased—Methotrexate—urinary bladder cancer	5.14e-05	0.000962	CcSEcCtD
Phenobarbital—Musculoskeletal discomfort—Doxorubicin—urinary bladder cancer	5.13e-05	0.00096	CcSEcCtD
Phenobarbital—Feeling abnormal—Epirubicin—urinary bladder cancer	5.01e-05	0.000939	CcSEcCtD
Phenobarbital—Somnolence—Doxorubicin—urinary bladder cancer	5e-05	0.000937	CcSEcCtD
Phenobarbital—Urticaria—Epirubicin—urinary bladder cancer	4.83e-05	0.000905	CcSEcCtD
Phenobarbital—Pain—Doxorubicin—urinary bladder cancer	4.81e-05	0.000901	CcSEcCtD
Phenobarbital—Constipation—Doxorubicin—urinary bladder cancer	4.81e-05	0.000901	CcSEcCtD
Phenobarbital—Body temperature increased—Epirubicin—urinary bladder cancer	4.81e-05	0.000901	CcSEcCtD
Phenobarbital—Hypersensitivity—Methotrexate—urinary bladder cancer	4.79e-05	0.000897	CcSEcCtD
Phenobarbital—Feeling abnormal—Doxorubicin—urinary bladder cancer	4.64e-05	0.000869	CcSEcCtD
Phenobarbital—Hypersensitivity—Epirubicin—urinary bladder cancer	4.48e-05	0.000839	CcSEcCtD
Phenobarbital—Urticaria—Doxorubicin—urinary bladder cancer	4.47e-05	0.000837	CcSEcCtD
Phenobarbital—Body temperature increased—Doxorubicin—urinary bladder cancer	4.45e-05	0.000833	CcSEcCtD
Phenobarbital—Dizziness—Methotrexate—urinary bladder cancer	4.3e-05	0.000805	CcSEcCtD
Phenobarbital—Hypersensitivity—Doxorubicin—urinary bladder cancer	4.15e-05	0.000777	CcSEcCtD
Phenobarbital—Vomiting—Methotrexate—urinary bladder cancer	4.13e-05	0.000774	CcSEcCtD
Phenobarbital—Rash—Methotrexate—urinary bladder cancer	4.1e-05	0.000768	CcSEcCtD
Phenobarbital—Dermatitis—Methotrexate—urinary bladder cancer	4.1e-05	0.000767	CcSEcCtD
Phenobarbital—Headache—Methotrexate—urinary bladder cancer	4.07e-05	0.000763	CcSEcCtD
Phenobarbital—Dizziness—Epirubicin—urinary bladder cancer	4.02e-05	0.000753	CcSEcCtD
Phenobarbital—Vomiting—Epirubicin—urinary bladder cancer	3.87e-05	0.000724	CcSEcCtD
Phenobarbital—Nausea—Methotrexate—urinary bladder cancer	3.86e-05	0.000723	CcSEcCtD
Phenobarbital—Rash—Epirubicin—urinary bladder cancer	3.84e-05	0.000718	CcSEcCtD
Phenobarbital—Dermatitis—Epirubicin—urinary bladder cancer	3.83e-05	0.000718	CcSEcCtD
Phenobarbital—Headache—Epirubicin—urinary bladder cancer	3.81e-05	0.000714	CcSEcCtD
Phenobarbital—Dizziness—Doxorubicin—urinary bladder cancer	3.72e-05	0.000697	CcSEcCtD
Phenobarbital—Nausea—Epirubicin—urinary bladder cancer	3.61e-05	0.000677	CcSEcCtD
Phenobarbital—Vomiting—Doxorubicin—urinary bladder cancer	3.58e-05	0.00067	CcSEcCtD
Phenobarbital—Rash—Doxorubicin—urinary bladder cancer	3.55e-05	0.000665	CcSEcCtD
Phenobarbital—Dermatitis—Doxorubicin—urinary bladder cancer	3.55e-05	0.000664	CcSEcCtD
Phenobarbital—Headache—Doxorubicin—urinary bladder cancer	3.53e-05	0.00066	CcSEcCtD
Phenobarbital—Nausea—Doxorubicin—urinary bladder cancer	3.34e-05	0.000626	CcSEcCtD
Phenobarbital—CYP1B1—Metabolism—ERCC2—urinary bladder cancer	4.83e-06	7.01e-05	CbGpPWpGaD
Phenobarbital—CYP2C18—Metabolism—CREBBP—urinary bladder cancer	4.79e-06	6.96e-05	CbGpPWpGaD
Phenobarbital—CYP2C9—Metabolism—NAT2—urinary bladder cancer	4.78e-06	6.93e-05	CbGpPWpGaD
Phenobarbital—CYP3A4—Metabolism—CYP4B1—urinary bladder cancer	4.73e-06	6.87e-05	CbGpPWpGaD
Phenobarbital—CYP2C8—Metabolism—HPGDS—urinary bladder cancer	4.69e-06	6.81e-05	CbGpPWpGaD
Phenobarbital—CYP2C8—Metabolism—ENO2—urinary bladder cancer	4.69e-06	6.81e-05	CbGpPWpGaD
Phenobarbital—ABCC1—Metabolism—MTHFR—urinary bladder cancer	4.69e-06	6.81e-05	CbGpPWpGaD
Phenobarbital—CYP3A7—Metabolism—TYMS—urinary bladder cancer	4.68e-06	6.8e-05	CbGpPWpGaD
Phenobarbital—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	4.66e-06	6.77e-05	CbGpPWpGaD
Phenobarbital—ABCC3—Metabolism—CREBBP—urinary bladder cancer	4.66e-06	6.77e-05	CbGpPWpGaD
Phenobarbital—CYP3A7—Metabolism—NCOR1—urinary bladder cancer	4.63e-06	6.72e-05	CbGpPWpGaD
Phenobarbital—CYP3A7—Metabolism—GSTM1—urinary bladder cancer	4.63e-06	6.72e-05	CbGpPWpGaD
Phenobarbital—CYP2A6—Metabolism—GSTP1—urinary bladder cancer	4.62e-06	6.7e-05	CbGpPWpGaD
Phenobarbital—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—urinary bladder cancer	4.56e-06	6.61e-05	CbGpPWpGaD
Phenobarbital—CYP2C8—Metabolism—GSTT1—urinary bladder cancer	4.55e-06	6.6e-05	CbGpPWpGaD
Phenobarbital—CYP1B1—Metabolism—MTHFR—urinary bladder cancer	4.54e-06	6.59e-05	CbGpPWpGaD
Phenobarbital—CYP1A2—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	4.53e-06	6.57e-05	CbGpPWpGaD
Phenobarbital—CYP2C19—Metabolism—RRM2—urinary bladder cancer	4.52e-06	6.56e-05	CbGpPWpGaD
Phenobarbital—CYP1A2—Metabolism—TYMP—urinary bladder cancer	4.51e-06	6.55e-05	CbGpPWpGaD
Phenobarbital—CYP4A11—Metabolism—PTGS2—urinary bladder cancer	4.49e-06	6.52e-05	CbGpPWpGaD
Phenobarbital—CYP2C8—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	4.48e-06	6.5e-05	CbGpPWpGaD
Phenobarbital—CYP3A4—Metabolism—SLC19A1—urinary bladder cancer	4.47e-06	6.49e-05	CbGpPWpGaD
Phenobarbital—CYP2B6—Metabolism—NQO1—urinary bladder cancer	4.47e-06	6.48e-05	CbGpPWpGaD
Phenobarbital—CYP3A7—Metabolism—GPX1—urinary bladder cancer	4.43e-06	6.43e-05	CbGpPWpGaD
Phenobarbital—ABCB1—Metabolism—RRM2—urinary bladder cancer	4.41e-06	6.41e-05	CbGpPWpGaD
Phenobarbital—CYP2E1—Metabolism—NQO1—urinary bladder cancer	4.37e-06	6.35e-05	CbGpPWpGaD
Phenobarbital—CYP3A5—Metabolism—NQO1—urinary bladder cancer	4.37e-06	6.34e-05	CbGpPWpGaD
Phenobarbital—ABCC1—Disease—CREBBP—urinary bladder cancer	4.36e-06	6.33e-05	CbGpPWpGaD
Phenobarbital—CYP3A4—Metabolism—PRSS3—urinary bladder cancer	4.36e-06	6.32e-05	CbGpPWpGaD
Phenobarbital—CYP3A7—Metabolism—ERCC2—urinary bladder cancer	4.35e-06	6.32e-05	CbGpPWpGaD
Phenobarbital—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	4.33e-06	6.29e-05	CbGpPWpGaD
Phenobarbital—CYP2A6—Metabolism—TYMS—urinary bladder cancer	4.29e-06	6.23e-05	CbGpPWpGaD
Phenobarbital—CYP2A6—Metabolism—NCOR1—urinary bladder cancer	4.24e-06	6.16e-05	CbGpPWpGaD
Phenobarbital—CYP2A6—Metabolism—GSTM1—urinary bladder cancer	4.24e-06	6.16e-05	CbGpPWpGaD
Phenobarbital—CYP2C19—Metabolism—HPGDS—urinary bladder cancer	4.19e-06	6.08e-05	CbGpPWpGaD
Phenobarbital—CYP2C19—Metabolism—ENO2—urinary bladder cancer	4.19e-06	6.08e-05	CbGpPWpGaD
Phenobarbital—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	4.16e-06	6.04e-05	CbGpPWpGaD
Phenobarbital—CYP1A1—Metabolism—NQO1—urinary bladder cancer	4.12e-06	5.99e-05	CbGpPWpGaD
Phenobarbital—CYP2C9—Metabolism—RRM2—urinary bladder cancer	4.12e-06	5.98e-05	CbGpPWpGaD
Phenobarbital—CYP3A7—Metabolism—MTHFR—urinary bladder cancer	4.09e-06	5.94e-05	CbGpPWpGaD
Phenobarbital—ABCB1—Metabolism—ENO2—urinary bladder cancer	4.09e-06	5.93e-05	CbGpPWpGaD
Phenobarbital—ABCB1—Metabolism—HPGDS—urinary bladder cancer	4.09e-06	5.93e-05	CbGpPWpGaD
Phenobarbital—CYP1A2—Metabolism—NAT2—urinary bladder cancer	4.08e-06	5.92e-05	CbGpPWpGaD
Phenobarbital—CYP2A6—Metabolism—GPX1—urinary bladder cancer	4.06e-06	5.9e-05	CbGpPWpGaD
Phenobarbital—CYP2C19—Metabolism—GSTT1—urinary bladder cancer	4.06e-06	5.9e-05	CbGpPWpGaD
Phenobarbital—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	4e-06	5.81e-05	CbGpPWpGaD
Phenobarbital—CYP2C19—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	4e-06	5.8e-05	CbGpPWpGaD
Phenobarbital—CYP2A6—Metabolism—ERCC2—urinary bladder cancer	3.99e-06	5.79e-05	CbGpPWpGaD
Phenobarbital—ABCB11—Metabolism—PTGS2—urinary bladder cancer	3.98e-06	5.78e-05	CbGpPWpGaD
Phenobarbital—ABCB1—Metabolism—GSTT1—urinary bladder cancer	3.96e-06	5.75e-05	CbGpPWpGaD
Phenobarbital—ABCC1—Disease—RHOA—urinary bladder cancer	3.95e-06	5.73e-05	CbGpPWpGaD
Phenobarbital—CYP2C18—Metabolism—PTGS2—urinary bladder cancer	3.93e-06	5.7e-05	CbGpPWpGaD
Phenobarbital—CYP4A11—Metabolism—PTEN—urinary bladder cancer	3.92e-06	5.69e-05	CbGpPWpGaD
Phenobarbital—ABCC3—Metabolism—PTGS2—urinary bladder cancer	3.82e-06	5.54e-05	CbGpPWpGaD
Phenobarbital—CYP2C9—Metabolism—HPGDS—urinary bladder cancer	3.82e-06	5.54e-05	CbGpPWpGaD
Phenobarbital—CYP2C9—Metabolism—ENO2—urinary bladder cancer	3.82e-06	5.54e-05	CbGpPWpGaD
Phenobarbital—ABCC1—Metabolism—PPARG—urinary bladder cancer	3.8e-06	5.52e-05	CbGpPWpGaD
Phenobarbital—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	3.8e-06	5.51e-05	CbGpPWpGaD
Phenobarbital—CYP2C8—Metabolism—NQO1—urinary bladder cancer	3.78e-06	5.49e-05	CbGpPWpGaD
Phenobarbital—CYP2A6—Metabolism—MTHFR—urinary bladder cancer	3.75e-06	5.44e-05	CbGpPWpGaD
Phenobarbital—CYP4A11—Metabolism—EP300—urinary bladder cancer	3.74e-06	5.42e-05	CbGpPWpGaD
Phenobarbital—CYP2B6—Metabolism—GSTP1—urinary bladder cancer	3.73e-06	5.41e-05	CbGpPWpGaD
Phenobarbital—ABCB1—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	3.71e-06	5.39e-05	CbGpPWpGaD
Phenobarbital—CYP2C9—Metabolism—GSTT1—urinary bladder cancer	3.7e-06	5.38e-05	CbGpPWpGaD
Phenobarbital—CYP1B1—Metabolism—PPARG—urinary bladder cancer	3.68e-06	5.34e-05	CbGpPWpGaD
Phenobarbital—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	3.67e-06	5.33e-05	CbGpPWpGaD
Phenobarbital—ABCC1—Metabolism—CREBBP—urinary bladder cancer	3.65e-06	5.3e-05	CbGpPWpGaD
Phenobarbital—ABCC1—Disease—ERBB2—urinary bladder cancer	3.65e-06	5.3e-05	CbGpPWpGaD
Phenobarbital—CYP2E1—Metabolism—GSTP1—urinary bladder cancer	3.65e-06	5.3e-05	CbGpPWpGaD
Phenobarbital—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	3.65e-06	5.29e-05	CbGpPWpGaD
Phenobarbital—CYP3A5—Metabolism—GSTP1—urinary bladder cancer	3.64e-06	5.29e-05	CbGpPWpGaD
Phenobarbital—ABCC1—Disease—PTGS2—urinary bladder cancer	3.57e-06	5.19e-05	CbGpPWpGaD
Phenobarbital—CYP1B1—Metabolism—CREBBP—urinary bladder cancer	3.53e-06	5.13e-05	CbGpPWpGaD
Phenobarbital—CYP1A2—Metabolism—RRM2—urinary bladder cancer	3.52e-06	5.11e-05	CbGpPWpGaD
Phenobarbital—CYP1A1—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	3.49e-06	5.07e-05	CbGpPWpGaD
Phenobarbital—CYP3A4—Metabolism—TYMP—urinary bladder cancer	3.48e-06	5.06e-05	CbGpPWpGaD
Phenobarbital—ABCB11—Metabolism—PTEN—urinary bladder cancer	3.47e-06	5.04e-05	CbGpPWpGaD
Phenobarbital—CYP2B6—Metabolism—TYMS—urinary bladder cancer	3.46e-06	5.03e-05	CbGpPWpGaD
Phenobarbital—CYP1A1—Metabolism—GSTP1—urinary bladder cancer	3.44e-06	4.99e-05	CbGpPWpGaD
Phenobarbital—CYP2B6—Metabolism—GSTM1—urinary bladder cancer	3.42e-06	4.97e-05	CbGpPWpGaD
Phenobarbital—CYP2B6—Metabolism—NCOR1—urinary bladder cancer	3.42e-06	4.97e-05	CbGpPWpGaD
Phenobarbital—CYP2C18—Metabolism—PTEN—urinary bladder cancer	3.42e-06	4.97e-05	CbGpPWpGaD
Phenobarbital—CYP2E1—Metabolism—TYMS—urinary bladder cancer	3.39e-06	4.92e-05	CbGpPWpGaD
Phenobarbital—CYP3A5—Metabolism—TYMS—urinary bladder cancer	3.39e-06	4.91e-05	CbGpPWpGaD
Phenobarbital—CYP2C19—Metabolism—NQO1—urinary bladder cancer	3.38e-06	4.9e-05	CbGpPWpGaD
Phenobarbital—CYP2E1—Metabolism—NCOR1—urinary bladder cancer	3.35e-06	4.87e-05	CbGpPWpGaD
Phenobarbital—CYP2E1—Metabolism—GSTM1—urinary bladder cancer	3.35e-06	4.87e-05	CbGpPWpGaD
Phenobarbital—CYP3A5—Metabolism—GSTM1—urinary bladder cancer	3.35e-06	4.86e-05	CbGpPWpGaD
Phenobarbital—CYP3A5—Metabolism—NCOR1—urinary bladder cancer	3.35e-06	4.86e-05	CbGpPWpGaD
Phenobarbital—ABCC3—Metabolism—PTEN—urinary bladder cancer	3.33e-06	4.83e-05	CbGpPWpGaD
Phenobarbital—CYP1A1—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	3.33e-06	4.83e-05	CbGpPWpGaD
Phenobarbital—CYP3A7—Metabolism—PPARG—urinary bladder cancer	3.32e-06	4.82e-05	CbGpPWpGaD
Phenobarbital—ABCB11—Metabolism—EP300—urinary bladder cancer	3.31e-06	4.81e-05	CbGpPWpGaD
Phenobarbital—ABCB1—Metabolism—NQO1—urinary bladder cancer	3.29e-06	4.78e-05	CbGpPWpGaD
Phenobarbital—CYP2B6—Metabolism—GPX1—urinary bladder cancer	3.28e-06	4.76e-05	CbGpPWpGaD
Phenobarbital—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	3.27e-06	4.75e-05	CbGpPWpGaD
Phenobarbital—CYP2C18—Metabolism—EP300—urinary bladder cancer	3.26e-06	4.74e-05	CbGpPWpGaD
Phenobarbital—CYP1A2—Metabolism—ENO2—urinary bladder cancer	3.26e-06	4.74e-05	CbGpPWpGaD
Phenobarbital—CYP1A2—Metabolism—HPGDS—urinary bladder cancer	3.26e-06	4.74e-05	CbGpPWpGaD
Phenobarbital—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	3.24e-06	4.71e-05	CbGpPWpGaD
Phenobarbital—CYP2B6—Metabolism—ERCC2—urinary bladder cancer	3.22e-06	4.67e-05	CbGpPWpGaD
Phenobarbital—CYP2E1—Metabolism—GPX1—urinary bladder cancer	3.21e-06	4.66e-05	CbGpPWpGaD
Phenobarbital—CYP3A5—Metabolism—GPX1—urinary bladder cancer	3.2e-06	4.65e-05	CbGpPWpGaD
Phenobarbital—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	3.2e-06	4.64e-05	CbGpPWpGaD
Phenobarbital—CYP1A1—Metabolism—TYMS—urinary bladder cancer	3.2e-06	4.64e-05	CbGpPWpGaD
Phenobarbital—CYP3A7—Metabolism—CREBBP—urinary bladder cancer	3.19e-06	4.63e-05	CbGpPWpGaD
Phenobarbital—ABCC3—Metabolism—EP300—urinary bladder cancer	3.18e-06	4.61e-05	CbGpPWpGaD
Phenobarbital—CYP1A2—Metabolism—GSTT1—urinary bladder cancer	3.16e-06	4.59e-05	CbGpPWpGaD
Phenobarbital—CYP1A1—Metabolism—NCOR1—urinary bladder cancer	3.16e-06	4.59e-05	CbGpPWpGaD
Phenobarbital—CYP1A1—Metabolism—GSTM1—urinary bladder cancer	3.16e-06	4.59e-05	CbGpPWpGaD
Phenobarbital—CYP2C8—Metabolism—GSTP1—urinary bladder cancer	3.15e-06	4.58e-05	CbGpPWpGaD
Phenobarbital—CYP2E1—Metabolism—ERCC2—urinary bladder cancer	3.15e-06	4.58e-05	CbGpPWpGaD
Phenobarbital—CYP3A4—Metabolism—NAT2—urinary bladder cancer	3.15e-06	4.57e-05	CbGpPWpGaD
Phenobarbital—CYP3A5—Metabolism—ERCC2—urinary bladder cancer	3.15e-06	4.57e-05	CbGpPWpGaD
Phenobarbital—ABCC1—Disease—CDKN1A—urinary bladder cancer	3.12e-06	4.53e-05	CbGpPWpGaD
Phenobarbital—CYP1A2—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	3.12e-06	4.52e-05	CbGpPWpGaD
Phenobarbital—ABCC1—Disease—PTEN—urinary bladder cancer	3.12e-06	4.52e-05	CbGpPWpGaD
Phenobarbital—CYP2C9—Metabolism—NQO1—urinary bladder cancer	3.08e-06	4.47e-05	CbGpPWpGaD
Phenobarbital—CYP2C8—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	3.05e-06	4.43e-05	CbGpPWpGaD
Phenobarbital—CYP2A6—Metabolism—PPARG—urinary bladder cancer	3.04e-06	4.41e-05	CbGpPWpGaD
Phenobarbital—CYP1A1—Metabolism—GPX1—urinary bladder cancer	3.03e-06	4.39e-05	CbGpPWpGaD
Phenobarbital—CYP2B6—Metabolism—MTHFR—urinary bladder cancer	3.03e-06	4.39e-05	CbGpPWpGaD
Phenobarbital—ABCC1—Metabolism—PTGS2—urinary bladder cancer	2.99e-06	4.34e-05	CbGpPWpGaD
Phenobarbital—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	2.99e-06	4.33e-05	CbGpPWpGaD
Phenobarbital—CYP1A1—Metabolism—ERCC2—urinary bladder cancer	2.97e-06	4.31e-05	CbGpPWpGaD
Phenobarbital—ABCC1—Disease—EP300—urinary bladder cancer	2.97e-06	4.31e-05	CbGpPWpGaD
Phenobarbital—CYP2E1—Metabolism—MTHFR—urinary bladder cancer	2.96e-06	4.3e-05	CbGpPWpGaD
Phenobarbital—CYP3A5—Metabolism—MTHFR—urinary bladder cancer	2.96e-06	4.29e-05	CbGpPWpGaD
Phenobarbital—CYP2C8—Metabolism—TYMS—urinary bladder cancer	2.93e-06	4.26e-05	CbGpPWpGaD
Phenobarbital—CYP2A6—Metabolism—CREBBP—urinary bladder cancer	2.92e-06	4.24e-05	CbGpPWpGaD
Phenobarbital—CYP2C8—Metabolism—GSTM1—urinary bladder cancer	2.9e-06	4.21e-05	CbGpPWpGaD
Phenobarbital—CYP2C8—Metabolism—NCOR1—urinary bladder cancer	2.9e-06	4.21e-05	CbGpPWpGaD
Phenobarbital—CYP1B1—Metabolism—PTGS2—urinary bladder cancer	2.89e-06	4.2e-05	CbGpPWpGaD
Phenobarbital—ABCC1—Disease—SRC—urinary bladder cancer	2.89e-06	4.19e-05	CbGpPWpGaD
Phenobarbital—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	2.86e-06	4.15e-05	CbGpPWpGaD
Phenobarbital—CYP2C19—Metabolism—GSTP1—urinary bladder cancer	2.82e-06	4.09e-05	CbGpPWpGaD
Phenobarbital—CYP1A1—Metabolism—MTHFR—urinary bladder cancer	2.79e-06	4.06e-05	CbGpPWpGaD
Phenobarbital—CYP2C8—Metabolism—GPX1—urinary bladder cancer	2.78e-06	4.03e-05	CbGpPWpGaD
Phenobarbital—ABCB1—Metabolism—GSTP1—urinary bladder cancer	2.75e-06	3.99e-05	CbGpPWpGaD
Phenobarbital—CYP2C8—Metabolism—ERCC2—urinary bladder cancer	2.72e-06	3.96e-05	CbGpPWpGaD
Phenobarbital—CYP2C19—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	2.72e-06	3.95e-05	CbGpPWpGaD
Phenobarbital—CYP3A4—Metabolism—RRM2—urinary bladder cancer	2.72e-06	3.95e-05	CbGpPWpGaD
Phenobarbital—CYP1A2—Metabolism—NQO1—urinary bladder cancer	2.63e-06	3.82e-05	CbGpPWpGaD
Phenobarbital—CYP2C19—Metabolism—TYMS—urinary bladder cancer	2.62e-06	3.8e-05	CbGpPWpGaD
Phenobarbital—CYP3A7—Metabolism—PTGS2—urinary bladder cancer	2.61e-06	3.79e-05	CbGpPWpGaD
Phenobarbital—ABCC1—Metabolism—PTEN—urinary bladder cancer	2.61e-06	3.79e-05	CbGpPWpGaD
Phenobarbital—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	2.6e-06	3.78e-05	CbGpPWpGaD
Phenobarbital—ABCC1—Disease—MYC—urinary bladder cancer	2.59e-06	3.76e-05	CbGpPWpGaD
Phenobarbital—CYP2C19—Metabolism—GSTM1—urinary bladder cancer	2.59e-06	3.76e-05	CbGpPWpGaD
Phenobarbital—CYP2C19—Metabolism—NCOR1—urinary bladder cancer	2.59e-06	3.76e-05	CbGpPWpGaD
Phenobarbital—CYP2C9—Metabolism—GSTP1—urinary bladder cancer	2.57e-06	3.73e-05	CbGpPWpGaD
Phenobarbital—CYP2C8—Metabolism—MTHFR—urinary bladder cancer	2.56e-06	3.72e-05	CbGpPWpGaD
Phenobarbital—ABCB1—Metabolism—TYMS—urinary bladder cancer	2.55e-06	3.71e-05	CbGpPWpGaD
Phenobarbital—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	2.55e-06	3.7e-05	CbGpPWpGaD
Phenobarbital—ABCC1—Disease—EGFR—urinary bladder cancer	2.53e-06	3.68e-05	CbGpPWpGaD
Phenobarbital—ABCB1—Metabolism—GSTM1—urinary bladder cancer	2.52e-06	3.67e-05	CbGpPWpGaD
Phenobarbital—ABCB1—Metabolism—NCOR1—urinary bladder cancer	2.52e-06	3.67e-05	CbGpPWpGaD
Phenobarbital—CYP1B1—Metabolism—PTEN—urinary bladder cancer	2.52e-06	3.66e-05	CbGpPWpGaD
Phenobarbital—CYP3A4—Metabolism—ENO2—urinary bladder cancer	2.52e-06	3.66e-05	CbGpPWpGaD
Phenobarbital—CYP3A4—Metabolism—HPGDS—urinary bladder cancer	2.52e-06	3.66e-05	CbGpPWpGaD
Phenobarbital—ABCC1—Metabolism—EP300—urinary bladder cancer	2.49e-06	3.61e-05	CbGpPWpGaD
Phenobarbital—CYP2C9—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	2.48e-06	3.6e-05	CbGpPWpGaD
Phenobarbital—CYP2C19—Metabolism—GPX1—urinary bladder cancer	2.48e-06	3.6e-05	CbGpPWpGaD
Phenobarbital—CYP2B6—Metabolism—PPARG—urinary bladder cancer	2.45e-06	3.56e-05	CbGpPWpGaD
Phenobarbital—CYP3A4—Metabolism—GSTT1—urinary bladder cancer	2.44e-06	3.55e-05	CbGpPWpGaD
Phenobarbital—CYP2C19—Metabolism—ERCC2—urinary bladder cancer	2.43e-06	3.53e-05	CbGpPWpGaD
Phenobarbital—ABCB1—Metabolism—GPX1—urinary bladder cancer	2.42e-06	3.51e-05	CbGpPWpGaD
Phenobarbital—CYP1B1—Metabolism—EP300—urinary bladder cancer	2.41e-06	3.49e-05	CbGpPWpGaD
Phenobarbital—CYP2E1—Metabolism—PPARG—urinary bladder cancer	2.4e-06	3.49e-05	CbGpPWpGaD
Phenobarbital—CYP3A5—Metabolism—PPARG—urinary bladder cancer	2.4e-06	3.48e-05	CbGpPWpGaD
Phenobarbital—ABCC1—Disease—KRAS—urinary bladder cancer	2.39e-06	3.47e-05	CbGpPWpGaD
Phenobarbital—CYP2A6—Metabolism—PTGS2—urinary bladder cancer	2.39e-06	3.47e-05	CbGpPWpGaD
Phenobarbital—CYP2C9—Metabolism—TYMS—urinary bladder cancer	2.39e-06	3.46e-05	CbGpPWpGaD
Phenobarbital—ABCB1—Metabolism—ERCC2—urinary bladder cancer	2.37e-06	3.45e-05	CbGpPWpGaD
Phenobarbital—CYP2C9—Metabolism—GSTM1—urinary bladder cancer	2.36e-06	3.42e-05	CbGpPWpGaD
Phenobarbital—CYP2C9—Metabolism—NCOR1—urinary bladder cancer	2.36e-06	3.42e-05	CbGpPWpGaD
Phenobarbital—CYP2B6—Metabolism—CREBBP—urinary bladder cancer	2.36e-06	3.42e-05	CbGpPWpGaD
Phenobarbital—CYP2E1—Metabolism—CREBBP—urinary bladder cancer	2.31e-06	3.35e-05	CbGpPWpGaD
Phenobarbital—CYP3A5—Metabolism—CREBBP—urinary bladder cancer	2.3e-06	3.34e-05	CbGpPWpGaD
Phenobarbital—CYP2C19—Metabolism—MTHFR—urinary bladder cancer	2.29e-06	3.32e-05	CbGpPWpGaD
Phenobarbital—CYP3A7—Metabolism—PTEN—urinary bladder cancer	2.28e-06	3.3e-05	CbGpPWpGaD
Phenobarbital—CYP1A1—Metabolism—PPARG—urinary bladder cancer	2.27e-06	3.29e-05	CbGpPWpGaD
Phenobarbital—CYP2C9—Metabolism—GPX1—urinary bladder cancer	2.26e-06	3.28e-05	CbGpPWpGaD
Phenobarbital—ABCB1—Metabolism—MTHFR—urinary bladder cancer	2.23e-06	3.24e-05	CbGpPWpGaD
Phenobarbital—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	2.23e-06	3.23e-05	CbGpPWpGaD
Phenobarbital—CYP2C9—Metabolism—ERCC2—urinary bladder cancer	2.22e-06	3.22e-05	CbGpPWpGaD
Phenobarbital—CYP1A2—Metabolism—GSTP1—urinary bladder cancer	2.19e-06	3.18e-05	CbGpPWpGaD
Phenobarbital—CYP1A1—Metabolism—CREBBP—urinary bladder cancer	2.18e-06	3.16e-05	CbGpPWpGaD
Phenobarbital—CYP3A7—Metabolism—EP300—urinary bladder cancer	2.17e-06	3.15e-05	CbGpPWpGaD
Phenobarbital—CYP1A2—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	2.12e-06	3.08e-05	CbGpPWpGaD
Phenobarbital—CYP2A6—Metabolism—PTEN—urinary bladder cancer	2.09e-06	3.03e-05	CbGpPWpGaD
Phenobarbital—CYP2C9—Metabolism—MTHFR—urinary bladder cancer	2.08e-06	3.03e-05	CbGpPWpGaD
Phenobarbital—CYP2C8—Metabolism—PPARG—urinary bladder cancer	2.08e-06	3.01e-05	CbGpPWpGaD
Phenobarbital—CYP1A2—Metabolism—TYMS—urinary bladder cancer	2.04e-06	2.96e-05	CbGpPWpGaD
Phenobarbital—ABCC1—Disease—HRAS—urinary bladder cancer	2.03e-06	2.95e-05	CbGpPWpGaD
Phenobarbital—CYP3A4—Metabolism—NQO1—urinary bladder cancer	2.03e-06	2.95e-05	CbGpPWpGaD
Phenobarbital—CYP1A2—Metabolism—NCOR1—urinary bladder cancer	2.02e-06	2.93e-05	CbGpPWpGaD
Phenobarbital—CYP1A2—Metabolism—GSTM1—urinary bladder cancer	2.02e-06	2.93e-05	CbGpPWpGaD
Phenobarbital—CYP2C8—Metabolism—CREBBP—urinary bladder cancer	2e-06	2.9e-05	CbGpPWpGaD
Phenobarbital—CYP2A6—Metabolism—EP300—urinary bladder cancer	1.99e-06	2.89e-05	CbGpPWpGaD
Phenobarbital—CYP1A2—Metabolism—GPX1—urinary bladder cancer	1.93e-06	2.8e-05	CbGpPWpGaD
Phenobarbital—CYP2B6—Metabolism—PTGS2—urinary bladder cancer	1.93e-06	2.8e-05	CbGpPWpGaD
Phenobarbital—CYP1A2—Metabolism—ERCC2—urinary bladder cancer	1.9e-06	2.75e-05	CbGpPWpGaD
Phenobarbital—CYP2E1—Metabolism—PTGS2—urinary bladder cancer	1.89e-06	2.74e-05	CbGpPWpGaD
Phenobarbital—CYP3A5—Metabolism—PTGS2—urinary bladder cancer	1.89e-06	2.74e-05	CbGpPWpGaD
Phenobarbital—CYP2C19—Metabolism—PPARG—urinary bladder cancer	1.85e-06	2.69e-05	CbGpPWpGaD
Phenobarbital—ABCB1—Metabolism—PPARG—urinary bladder cancer	1.81e-06	2.63e-05	CbGpPWpGaD
Phenobarbital—CYP1A1—Metabolism—PTGS2—urinary bladder cancer	1.78e-06	2.59e-05	CbGpPWpGaD
Phenobarbital—CYP1A2—Metabolism—MTHFR—urinary bladder cancer	1.78e-06	2.59e-05	CbGpPWpGaD
Phenobarbital—CYP2C19—Metabolism—CREBBP—urinary bladder cancer	1.78e-06	2.59e-05	CbGpPWpGaD
Phenobarbital—ABCB1—Metabolism—CREBBP—urinary bladder cancer	1.74e-06	2.52e-05	CbGpPWpGaD
Phenobarbital—CYP3A4—Metabolism—GSTP1—urinary bladder cancer	1.69e-06	2.46e-05	CbGpPWpGaD
Phenobarbital—CYP2C9—Metabolism—PPARG—urinary bladder cancer	1.69e-06	2.45e-05	CbGpPWpGaD
Phenobarbital—CYP2B6—Metabolism—PTEN—urinary bladder cancer	1.68e-06	2.44e-05	CbGpPWpGaD
Phenobarbital—CYP2E1—Metabolism—PTEN—urinary bladder cancer	1.65e-06	2.39e-05	CbGpPWpGaD
Phenobarbital—CYP3A5—Metabolism—PTEN—urinary bladder cancer	1.65e-06	2.39e-05	CbGpPWpGaD
Phenobarbital—CYP2C8—Metabolism—PTGS2—urinary bladder cancer	1.63e-06	2.37e-05	CbGpPWpGaD
Phenobarbital—CYP2C9—Metabolism—CREBBP—urinary bladder cancer	1.62e-06	2.36e-05	CbGpPWpGaD
Phenobarbital—CYP2B6—Metabolism—EP300—urinary bladder cancer	1.61e-06	2.33e-05	CbGpPWpGaD
Phenobarbital—CYP3A4—Metabolism—TYMS—urinary bladder cancer	1.57e-06	2.28e-05	CbGpPWpGaD
Phenobarbital—CYP2E1—Metabolism—EP300—urinary bladder cancer	1.57e-06	2.28e-05	CbGpPWpGaD
Phenobarbital—CYP3A5—Metabolism—EP300—urinary bladder cancer	1.57e-06	2.28e-05	CbGpPWpGaD
Phenobarbital—CYP3A4—Metabolism—NCOR1—urinary bladder cancer	1.56e-06	2.26e-05	CbGpPWpGaD
Phenobarbital—CYP3A4—Metabolism—GSTM1—urinary bladder cancer	1.56e-06	2.26e-05	CbGpPWpGaD
Phenobarbital—CYP1A1—Metabolism—PTEN—urinary bladder cancer	1.55e-06	2.26e-05	CbGpPWpGaD
Phenobarbital—CYP3A4—Metabolism—GPX1—urinary bladder cancer	1.49e-06	2.16e-05	CbGpPWpGaD
Phenobarbital—CYP1A1—Metabolism—EP300—urinary bladder cancer	1.48e-06	2.15e-05	CbGpPWpGaD
Phenobarbital—CYP3A4—Metabolism—ERCC2—urinary bladder cancer	1.46e-06	2.12e-05	CbGpPWpGaD
Phenobarbital—CYP2C19—Metabolism—PTGS2—urinary bladder cancer	1.46e-06	2.12e-05	CbGpPWpGaD
Phenobarbital—CYP1A2—Metabolism—PPARG—urinary bladder cancer	1.44e-06	2.1e-05	CbGpPWpGaD
Phenobarbital—CYP2C8—Metabolism—PTEN—urinary bladder cancer	1.42e-06	2.07e-05	CbGpPWpGaD
Phenobarbital—ABCB1—Metabolism—PTGS2—urinary bladder cancer	1.42e-06	2.07e-05	CbGpPWpGaD
Phenobarbital—CYP1A2—Metabolism—CREBBP—urinary bladder cancer	1.39e-06	2.01e-05	CbGpPWpGaD
Phenobarbital—CYP3A4—Metabolism—MTHFR—urinary bladder cancer	1.37e-06	2e-05	CbGpPWpGaD
Phenobarbital—CYP2C8—Metabolism—EP300—urinary bladder cancer	1.36e-06	1.97e-05	CbGpPWpGaD
Phenobarbital—CYP2C9—Metabolism—PTGS2—urinary bladder cancer	1.33e-06	1.93e-05	CbGpPWpGaD
Phenobarbital—CYP2C19—Metabolism—PTEN—urinary bladder cancer	1.27e-06	1.85e-05	CbGpPWpGaD
Phenobarbital—ABCB1—Metabolism—PTEN—urinary bladder cancer	1.24e-06	1.8e-05	CbGpPWpGaD
Phenobarbital—CYP2C19—Metabolism—EP300—urinary bladder cancer	1.21e-06	1.76e-05	CbGpPWpGaD
Phenobarbital—ABCB1—Metabolism—EP300—urinary bladder cancer	1.18e-06	1.72e-05	CbGpPWpGaD
Phenobarbital—CYP2C9—Metabolism—PTEN—urinary bladder cancer	1.16e-06	1.68e-05	CbGpPWpGaD
Phenobarbital—CYP1A2—Metabolism—PTGS2—urinary bladder cancer	1.14e-06	1.65e-05	CbGpPWpGaD
Phenobarbital—CYP3A4—Metabolism—PPARG—urinary bladder cancer	1.11e-06	1.62e-05	CbGpPWpGaD
Phenobarbital—CYP2C9—Metabolism—EP300—urinary bladder cancer	1.11e-06	1.61e-05	CbGpPWpGaD
Phenobarbital—CYP3A4—Metabolism—CREBBP—urinary bladder cancer	1.07e-06	1.55e-05	CbGpPWpGaD
Phenobarbital—CYP1A2—Metabolism—PTEN—urinary bladder cancer	9.91e-07	1.44e-05	CbGpPWpGaD
Phenobarbital—CYP1A2—Metabolism—EP300—urinary bladder cancer	9.45e-07	1.37e-05	CbGpPWpGaD
Phenobarbital—CYP3A4—Metabolism—PTGS2—urinary bladder cancer	8.77e-07	1.27e-05	CbGpPWpGaD
Phenobarbital—CYP3A4—Metabolism—PTEN—urinary bladder cancer	7.65e-07	1.11e-05	CbGpPWpGaD
Phenobarbital—CYP3A4—Metabolism—EP300—urinary bladder cancer	7.29e-07	1.06e-05	CbGpPWpGaD
